April, 14, 2021 – Elixir Medical recently announced the first patient was treated in the BIOADAPTOR randomized controlled trial (RCT) of the DynamX Coronary Bioadaptor System, the first drug-eluting coronary stent that adapts to vessel physiology.

April 14, 2021 — The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical AcQCross family of universal transseptal crossing devices. This is the only transseptal puncture system specifically engineered to pair and mate seamlessly with Acutus’ own suite of sheaths and with sheaths sold by other manufacturers. 

CDC and FDA Call for Pause on Janssen COVID-19 Vaccine Due to Rare Blood Clots #COVID19 #Janssen

(This story was updated May 7, 2021 in the last subheaded section)
Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) devices because of an unexpected and rapid decrease in battery life. The company said this is due to a short circuit and will cause some devices to produce a “Recommended Replacement Time” (first warning that the battery is low) earlier than expected. Some devices may progress from “Recommended Replacement Time” to full battery depletion within as little as one day.

April 12, 2021 — Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) devices because of an unexpected and rapid decrease in battery life.

Controversies and Advances in the Treatment of Cardiovascular Disease

Controversies & Advances in the Treatment of Cardiovascular Disease: The Twentieth in the Series, December 2-3, 2021, at the Maybourne Beverly Hills, Beverly Hills, California

 

Cardiovascular Interventions

32nd Annual Cardiovascular Interventions, November 16-19, 2021, at the Hilton La Jolla Torrey Pines, La Jolla, California

 

 

April 8, 2021 — Abbott today announced it has received European CE mark and Health Canada authorization this week for its next-generation TriClip Transcatheter Tricuspid Valve Repair (TTVR) System, a minimally invasive tricuspid heart valve repair device to treat tricuspid regurgitation (TR).

April 7, 2021 — Philips Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Philips SmartCT application software, which is a component of Philips Azurion Image Guided Therapy System.

April 7, 2021 — Stereotaxis announced that Broward Health Medical Center is establishing a robotic electrophysiology (EP) program to expand access to advanced minimally-invasive treatment of heart rhythm disorders in Florida.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now